Compound 1545
Identifiers
- Canonical SMILES:
CC(C)(C)Cc1nc(C(O)=O)c(-c2ccc(F)c(Cl)c2)n1-c1cccc(Cl)c1F
- InChi:
InChI=1S/C21H18Cl2F2N2O2/c1-21(2,3)10-16-26-18(20(28)29)19(11-7-8-14(24)13(23)9-11)27(16)15-6-4-5-12(22)17(15)25/h4-9H,10H2,1-3H3,(H,28,29)
- InChiKey:
XIXMTPFRXZNMDO-UHFFFAOYSA-N
External links
![]() 67032048 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MDM2-Like / P53 | 7.94 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 438.07 g/mol | |||
HBA | 4 | |||
HBD | 1 | |||
HBA + HBD | 5 | |||
AlogP | 3.95 | |||
TPSA | 55.12 | |||
RB | 4 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2011023677 | 254 | MDM2 Q00987 |
|
Biochemical assay | Time-Resolved FRET | pIC50 (half maximal inhibitory concentration, -log10) | 7.94 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5288 | Azeliragon | DB12689 | |
0.5000 | Olmesartan | DB00275 | |
0.4664 | Ralimetinib | DB11787 | |
0.4593 | N-6022 | DB12206 | |
0.4530 | Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine | DB03084 | |
0.4502 | LY-2584702 | DB12690 | |
0.4492 | Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine | DB02388 | |
0.4439 | Telmisartan | DB00966 | |
0.4424 | Cimicoxib | DB05095 | |
0.4424 | Losartan | DB00678 | |
0.4303 | Atorvastatin | DB01076 | |
0.4271 | 4-(4-FLUOROPHENYL)-1-CYCLOROPROPYLMETHYL-5-(4-PYRIDYL)-IMIDAZOLE | DB08522 | |
0.4252 | Gluco-Phenylimidazole | DB02862 | |
0.4219 | Flumazenil | DB01205 | |
0.4152 | Otenabant | DB11745 |